The European neurostimulation device market has been strongly impacted by the\u00a0COVID-19\u00a0pandemic; however, following this impact, it will\u00a0grow modestly, fueled by the ongoing product innovation to improve treatment efficacy and to address new indications, favorable demographic trends, new competitors entering the market, and ongoing postmarket clinical studies. However, limited reimbursement and the preference for alternative treatments in the neurostimulation device market segments will limit the growth of the overall market.<\/p>\n
This Medtech 360 Report provides key market metrics for\u00a0neurostimulation devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across an 11-year period.<\/p>\n","protected":false},"template":"","class_list":["post-385985","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-neurostimulation-devices","medtech-therapy-area-other-medical-technology","medtech-geography-europe","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385985\/revisions"}],"predecessor-version":[{"id":387494,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385985\/revisions\/387494"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}